PositiveID's Firefly Dx System Featured on Fox News San Francisco
August 07, 2014 10:41 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Aug. 7, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced...
Rand Capital Announces Net Asset Value of $4.43, Two New Investments and Five Follow-On Investments
July 31, 2014 15:59 ET
|
Rand Capital Corporation
Net Asset Value increases to $4.43 per share, a 1.8% ($.08) increase from prior quarter
Seven investments totaling $4 million represents busiest quarter in recent history
Notable...
PositiveID Receives New Order to Support M-BAND System for U.S. Government Contract
July 17, 2014 07:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., July 17, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced...
MolecularMD Develops Notch1 Next Generation Sequencing Test to Support Clinical Development for OncoMed's Anti-Notch1 Antibody, OMP-52M51
June 12, 2014 07:54 ET
|
MolecularMD
PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - Jun 12, 2014) - MolecularMD Corp., a molecular diagnostics company that provides custom companion diagnostic solutions and supporting clinical trial...
Provista Diagnostics Announces First Patient Enrolled in Prospective, Proof-of-Concept Study of its Protein Biomarker Blood Test to Assess the Presence of Breast Cancer
May 19, 2014 05:00 ET
|
Provista Diagnostics, Inc.
New York, NY, May 19, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company
developing and commercializing proteomic-based diagnostic,
prognostic and monitoring tests...
PositiveID Corporation Teaming Partner Leidos Awarded Defense Threat Reduction Agency Contract Valued at Up to $4 Billion
April 24, 2014 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., April 24, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced that its...
Provista Diagnostics Secures $6MM Series B Financing
April 16, 2014 05:00 ET
|
Provista Diagnostics, Inc.
Scottsdale, Arizona, April 16, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately held molecular
diagnostics company developing and commercializing diagnostic,
prognostic and predictive...
MolecularMD Receives CLIA Certification for Its Second Next Generation Sequencing Laboratory
April 04, 2014 07:00 ET
|
MolecularMD
PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - Apr 4, 2014) - MolecularMD, Inc., a molecular diagnostics company that provides custom companion diagnostic solutions and supporting clinical trial...
MolecularMD Launches NanoString Platform for Multiplexed Digital Evaluation of Gene Expression and Copy Number Variation in Clinical Specimens
March 05, 2014 07:00 ET
|
MolecularMD
PORTLAND, OR--(Marketwired - Mar 5, 2014) - MolecularMD Corp. today announced that it has launched the NanoString nCounter® Analysis System for multiplex biomarker evaluation in support of...
MolecularMD to Develop Highly Sensitive Companion Diagnostic Test to Support CML Treatment Free Remission Clinical Trials
February 19, 2014 07:00 ET
|
MolecularMD
PORTLAND, OR--(Marketwired - Feb 19, 2014) - MolecularMD Corp. today announced that it has entered into a collaboration with Novartis Pharmaceuticals Corporation to develop a companion diagnostic...